… 9 Innamorato NGJazwa ARojo AIGarcía CFernández-Ruiz JGrochot-Przeczek AStachurska
AJozkowicz ADulak JCuadrado ADifferent susceptibility to the Parkinson's toxin MPTP in …

Opioids and cannabinoids are among the most widely consumed drugs of abuse in humans.
A number of studies have shown that both types of drugs share several pharmacological …

To present a summary of current scientific evidence about the cannabinoid, cannabidiol (
CBD ) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders. …

Cannabinoids have been reported to provide neuroprotection in acute and chronic
neurodegeneration. In this study, we examined whether they are also effective against the toxicity …

Background Parkinson's disease (PD) is an adult-onset movement disorder of largely unknown
etiology. We have previously shown that loss-of-function mutations of the mitochondrial …

To investigate the mechanisms involved in cannabidiol (CBD)-induced neuroprotection in
hypoxic–ischemic (HI) immature brain, forebrain slices from newborn mice underwent oxygen …

We have recently demonstrated that two plant-derived cannabinoids, Δ 9 -tetrahydrocannabinol
and cannabidiol (CBD), are neuroprotective in an animal model of Parkinson's disease (…

Despite recent data suggesting that the endocannabinoid transmission is a component of
the brain reward system and plays a role in dependence/withdrawal to different habit-forming …

Cannabinoid receptors and their endogenous ligands constitute a novel modulatory system
that is involved in specific brain functions, such as nociception, control of movement, …

Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders
exerted through molecular mechanisms that are yet to be completely identified. CBD acts …